Cambium Bio Ltd (cmb) Logo

Cambium Bio Ltd (CMB)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

CMB ASX Chart

Snapshot

Cambium Bio Limited (CMB) is a Sydney-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue repair applications.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +79.94%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,887 of 2,339
Sector Rank 179 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies 1AD / IVXDB / BPH
EPS -$0.14
DPS $0.00
Book Value Per Share $0.095

Broker Consensus

CMB is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Bella Vista NSW 2153
Website www.cambium.bio
Registry MUFG Corporate Markets (AU) Limited
Auditor Stantons International Audit & Consulting Pty Ltd
Date Listed 19 Sep 2013

Upcoming Calendar (Forecasted)

Date Event
28/08/2026 Report (Prelim)
28/08/2026 Report (Annual)
19/02/2027 Report (Interim)

Former Company Names

  • Regeneus Ltd (RGS), 10/04/2024

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

CMB directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
17/03/26 Yu-Hung Tseng Issued 4,363,637 $0.55 $2,400,000 Placement
16/10/25 Terence Walts Issued 54,950 $0.464 $25,480 Placement
16/10/25 Terence Walts Issued 120,000 $0.46 $55,200 Director remuneration
16/10/25 Edmund Waller Issued 60,000 $0.464 $27,822 Placement
16/10/25 Edmund Waller Issued 120,000 $0.46 $55,200 Director remuneration
12/03/25 Terence Walts Issued 120,000 $0.35 $42,000 Director remuneration
12/03/25 Terence Walts Issued 54,950 $0.464 $25,480 Placement
12/03/25 Terence Walts Issued 50,000 $0.464 $23,185 Placement
12/03/25 Edmund Waller Issued 50,000 $0.464 $23,185 Placement
12/03/25 Yu-Hung Tseng Issued 3,773,993 $0.464 $1,750,000 Placement
12/03/25 Yu-Hung Tseng Issued 215,657 $2.76 $595,479 Placement
12/03/25 Chandra Bala Issued 50,000 $0.464 $23,185 Placement
12/03/25 Chandra Bala Issued 120,000 $0.35 $42,000 Issue of options
28/06/24 Yu-Hung Tseng Issued 175,469,372 $0.006 $1,052,816 As advised by the company
28/06/24 Yu-Hung Tseng Issued 17,546,938 $0.006 $105,282 As advised by the company

Director Interests

The current holdings of CMB directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Yu-Hung Tseng 17/03/2026 454,093 10,862,136 N/A N/A
Edmund Waller 16/10/2025 338,932 N/A 120,000 N/A
Terence Walts 16/10/2025 370,958 N/A 120,000 N/A
Li Chiu 30/06/2025 800,357 N/A N/A N/A
Chandra Bala 30/06/2025 50,000 N/A 120,000 N/A
ChiTai Chang 30/06/2025 N/A 2,384,359 N/A N/A
Denese Marks 21/05/2025 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 19, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Zheng Yang Biomedical Technology Limited 6,462,499 35.35%
Cyntec Co Ltd (Orient Euro Pharma) 2,384,359 13.04%
Treasury Century Group Limited 999,002 5.46%
Li Chien Ken Chiu 800,357 4.38%
Apex Metro Investments Limited 691,580 3.78%
Chen Yu Chen 539,142 2.95%
Yu Hung Sebastian Tseng 454,093 2.48%
Whale Watch Holdings Limited 400,000 2.19%
Mu Ni Chiu 317,915 1.74%
Citicorp Nominees Pty Limited 316,171 1.73%
Edmund Kemp Waller 278,932 1.53%
BNP Paribas Nominees Pty Ltd 234,203 1.28%
Terence Allen Walts 222,905 1.22%
HSBC Custody Nominees (Australia) Limited 214,445 1.17%
John Donald Roback 192,100 1.05%
Jennifer Heather Copland 185,472 1.01%
Jacques Galipeau 183,636 1.00%
Mr Bilal Ahmad 163,968 0.90%
Mrs Julia Caroline Hughes 161,068 0.88%
1215 Capital Pty Ltd 124,709 0.69%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 1,039 192 42 55 23 1,351

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Apex Metro Investments Limited 19/08/2025 691,580 3.74
Treasure Century Group Limited 19/08/2025 999,002 5.41
Cyntec Co Ltd 19/08/2025 2,384,359 12.91
Zheng Yang Biomedical Technology Co Ltd 19/08/2025 2,688,506 14.56
Li-Chien Ken Chiu 19/08/2025 800,357 4.33

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.21 30 June
2024 $0.005 28 June
2023 $0.007 30 June
2022 $0.061 30 June
2021 $0.074 30 June
2020 $0.07 30 June
2019 $0.085 28 June
2018 $0.12 29 June
2017 $0.115 30 June
2016 $0.125 30 June
2015 $0.15 30 June
2014 $0.39 30 June
CMB Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.